Dynamic Measures of Neurochemistry in Mood Disorders.
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Bupropion (Primary) ; Sertraline (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics
- 07 Apr 2017 Status changed from active, no longer recruiting to completed.
- 23 Mar 2011 Planned End Date changed from 1 Jun 2010 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 16 Jan 2010 New trial record